Medicyte now with online shop for upcyte® hepatocytes and innovative cell products
February 27, 2012
Heidelberg/Germany - The biotechnology company Medicyte is now offering its customers innovative cells and culture media for cell-based research at its online shop www.medicyte.com. After many years of intensive development especially focused on hepatocytes, Medicyte is now bringing its innovative consumables on to the market. In its newly-established online shop at the improved company website, [...]
Nanostart holding Lumiphore announces European launch of diagnostic tests
February 27, 2012
Frankfurt / Richmond, Calif. – Nanostart holding Lumiphore announced the European launch of three diagnostic tests by its partner ThermoFisher Scientific Clinical Diagnostics using Lumiphore’s time-resolved fluorescent reporter technology. ThermoFisher Clinical Diagnostics has launched three CE-marked in vitro diagnostic tests in countries of the European Economic Area (EEA), consisting of the 27 Member States of [...]
EMD Millipore Opens First Lab Water Production Site in China
February 27, 2012
Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA* of Germany, today inaugurated its lab water production site in Shanghai. The facility will manufacture the Ming Che™ product line of tailor-made lab water purification systems and consumables targeted to meet the demands of the Chinese market, and will be sold exclusively in [...]
New resource opens the door for enzyme research
February 27, 2012
Hinxton - The EMBL-European Bioinformatics Institute has launched the Enzyme Portal, a new resource for people who are interested in the biology of enzymes and proteins with enzymatic activity. Enzymes catalyse the myriad reactions that take place in living organisms, allowing chemical changes to occur that would otherwise need conditions that are incompatible with life. [...]
Repligen Launches New Products in OPUS™ Line of Pre-Packed Chromatography Columns
February 27, 2012
WALTHAM, MA – Repligen Corporation (NASDAQ:RGEN) today announced the launch of its new larger-scale OPUS™ brand chromatography columns used in the manufacture of biopharmaceuticals. The OPUS™ (Open Platform User Specified) line extension is being introduced in response to rising market demand for disposable technologies in biopharmaceutical manufacturing. Such technologies are revolutionizing biomanufacturing by enabling increased [...]
February 27, 2012
Hopkinton, Mass. – Hamilton Storage Technologies announced today the sale of a new -80°C BiOS third-generation biobanking system to the Netherlands Forensic Institute (NFI) for long-term storage of DNA extracts from crime scenes. The NFI performs the vast majority of all forensic DNA casework in the country, including providing second opinions and analyses for cold [...]
Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis
February 26, 2012
Munich, Germany - Nanion acquires the well-established SURFE2R technology, allowing state-of-the-art measurements of transporter protein activity and function. The SURFE2R technology is an excellent enhancement to Nanion’s existing products which until now covered ion channels and nanopores. Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. Nanion’s efficient and [...]
Certara Announces Acquisition Agreement with Simcyp Limited
February 24, 2012
ST. LOUIS, MO - Certara™, a leading provider of drug discovery and development software and scientific consulting services and a Vector portfolio company, today announced agreement to acquire Simcyp Limited. Simcyp is a UK-based, leading research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations, including pediatric populations. [...]
Study Published in Journal Nature Suggests New Genomic Pathways for Neuroblastoma
February 24, 2012
MOUNTAIN VIEW, Calif. – Complete Genomics, Inc. (NASDAQ: GNOM) announced today that the journal Nature has published a neuroblastoma study conducted using the company’s high-depth whole human genome sequencing service. The company believes that this is not only the most comprehensive genomic analysis of neuroblastoma published to date, but also the largest whole-genome survey of [...]
February 24, 2012
Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class research into business, is pleased to announce that Certara LP (“Certara”), a leading provider of drug discovery and development software and scientific consulting services, has agreed to acquire Fusion?s portfolio company, Simcyp Limited (“Simcyp”), for $32M. Simcyp is a leading research-based [...]
